Newswise — TAMPA, Fla. — Moffitt Cancer Center has been awarded a four-year, $3 million grant from the Department of Defense’s Congressionally Directed Medical Research Programs to develop new treatments for rare melanomas, including uveal melanoma. The grant will fund two projects aimed at advancing targeted alpha-particle therapies.
Patients
Melanoma: causes, identification and diagnosis
The British broadcaster and DJ, Chris Evans, has revealed that he has been diagnosed with a skin cancer called a “melanoma”. The 57-year-old says that he was tested for the disease after his masseuse noticed a mark on his shin. So, what exactly is melanoma? Julia Newton-Bishop is a professor of dermatology at the University of Leeds…
Breakthrough melanoma treatment saves grandfather’s eyesight
Blind in his left eye after a stroke three years ago, 70 year old Geoff was fully reliant on his right eye.
A drug for heart conditions improves efficacy of melanoma therapies
A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, ??Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d’Alacant, Valencian Community) and IRB Barcelona (Barcelona, ??Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease.